nodes	percent_of_prediction	percent_of_DWPC	metapath
Mupirocin—Application site burn—Fluorouracil—pancreatic cancer	0.0432	0.0438	CcSEcCtD
Mupirocin—Rash generalised—Sunitinib—pancreatic cancer	0.027	0.0274	CcSEcCtD
Mupirocin—Application site pain—Fluorouracil—pancreatic cancer	0.0206	0.0209	CcSEcCtD
Mupirocin—Rash generalised—Docetaxel—pancreatic cancer	0.0154	0.0156	CcSEcCtD
Mupirocin—Tenderness—Tamoxifen—pancreatic cancer	0.0154	0.0156	CcSEcCtD
Mupirocin—Tenderness—Erlotinib—pancreatic cancer	0.0152	0.0154	CcSEcCtD
Mupirocin—Blepharitis—Fluorouracil—pancreatic cancer	0.0147	0.0149	CcSEcCtD
Mupirocin—Cellulitis—Erlotinib—pancreatic cancer	0.0146	0.0148	CcSEcCtD
Mupirocin—Cellulitis—Sunitinib—pancreatic cancer	0.0126	0.0128	CcSEcCtD
Mupirocin—Sensitisation—Epirubicin—pancreatic cancer	0.0124	0.0125	CcSEcCtD
Mupirocin—Sensitisation—Doxorubicin—pancreatic cancer	0.0114	0.0116	CcSEcCtD
Mupirocin—Stinging—Fluorouracil—pancreatic cancer	0.0112	0.0113	CcSEcCtD
Mupirocin—Swelling—Tamoxifen—pancreatic cancer	0.011	0.0112	CcSEcCtD
Mupirocin—Tenderness—Gemcitabine—pancreatic cancer	0.0106	0.0107	CcSEcCtD
Mupirocin—Tenderness—Fluorouracil—pancreatic cancer	0.0104	0.0105	CcSEcCtD
Mupirocin—Mouth ulceration—Sunitinib—pancreatic cancer	0.0104	0.0105	CcSEcCtD
Mupirocin—Furunculosis—Epirubicin—pancreatic cancer	0.0104	0.0105	CcSEcCtD
Mupirocin—Cellulitis—Gemcitabine—pancreatic cancer	0.0101	0.0103	CcSEcCtD
Mupirocin—Cellulitis—Fluorouracil—pancreatic cancer	0.00996	0.0101	CcSEcCtD
Mupirocin—Furunculosis—Doxorubicin—pancreatic cancer	0.0096	0.00973	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Epirubicin—pancreatic cancer	0.00955	0.00968	CcSEcCtD
Mupirocin—Eczema—Sunitinib—pancreatic cancer	0.00928	0.0094	CcSEcCtD
Mupirocin—Furuncle—Epirubicin—pancreatic cancer	0.00899	0.00912	CcSEcCtD
Mupirocin—Dermatitis contact—Fluorouracil—pancreatic cancer	0.00895	0.00908	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Doxorubicin—pancreatic cancer	0.00884	0.00896	CcSEcCtD
Mupirocin—Dry skin—Erlotinib—pancreatic cancer	0.00883	0.00895	CcSEcCtD
Mupirocin—Furuncle—Doxorubicin—pancreatic cancer	0.00832	0.00843	CcSEcCtD
Mupirocin—Dry skin—Sunitinib—pancreatic cancer	0.00764	0.00775	CcSEcCtD
Mupirocin—Swelling—Fluorouracil—pancreatic cancer	0.00746	0.00756	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Irinotecan—pancreatic cancer	0.00728	0.00738	CcSEcCtD
Mupirocin—Epistaxis—Erlotinib—pancreatic cancer	0.007	0.00709	CcSEcCtD
Mupirocin—Haemoglobin—Tamoxifen—pancreatic cancer	0.00677	0.00686	CcSEcCtD
Mupirocin—Haemorrhage—Tamoxifen—pancreatic cancer	0.00673	0.00682	CcSEcCtD
Mupirocin—Haemoglobin—Erlotinib—pancreatic cancer	0.0067	0.00679	CcSEcCtD
Mupirocin—Pharyngitis—Tamoxifen—pancreatic cancer	0.00668	0.00677	CcSEcCtD
Mupirocin—Haemorrhage—Erlotinib—pancreatic cancer	0.00666	0.00675	CcSEcCtD
Mupirocin—Epistaxis—Sunitinib—pancreatic cancer	0.00606	0.00614	CcSEcCtD
Mupirocin—Dry skin—Fluorouracil—pancreatic cancer	0.00603	0.00611	CcSEcCtD
Mupirocin—Erythema—Tamoxifen—pancreatic cancer	0.00586	0.00594	CcSEcCtD
Mupirocin—IARS—islet of Langerhans—pancreatic cancer	0.0058	0.434	CbGeAlD
Mupirocin—Erythema—Erlotinib—pancreatic cancer	0.0058	0.00588	CcSEcCtD
Mupirocin—Haemoglobin—Sunitinib—pancreatic cancer	0.0058	0.00588	CcSEcCtD
Mupirocin—Haemorrhage—Sunitinib—pancreatic cancer	0.00577	0.00585	CcSEcCtD
Mupirocin—Dysgeusia—Tamoxifen—pancreatic cancer	0.00574	0.00582	CcSEcCtD
Mupirocin—Stinging—Epirubicin—pancreatic cancer	0.00544	0.00552	CcSEcCtD
Mupirocin—Swelling—Docetaxel—pancreatic cancer	0.00538	0.00545	CcSEcCtD
Mupirocin—Angioedema—Tamoxifen—pancreatic cancer	0.00536	0.00543	CcSEcCtD
Mupirocin—Immune system disorder—Sunitinib—pancreatic cancer	0.00521	0.00528	CcSEcCtD
Mupirocin—Cough—Tamoxifen—pancreatic cancer	0.00512	0.00518	CcSEcCtD
Mupirocin—Cough—Erlotinib—pancreatic cancer	0.00506	0.00513	CcSEcCtD
Mupirocin—Stinging—Doxorubicin—pancreatic cancer	0.00504	0.00511	CcSEcCtD
Mupirocin—Erythema—Sunitinib—pancreatic cancer	0.00502	0.00509	CcSEcCtD
Mupirocin—Dysgeusia—Sunitinib—pancreatic cancer	0.00492	0.00498	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.0049	0.00497	CcSEcCtD
Mupirocin—Dry mouth—Tamoxifen—pancreatic cancer	0.00488	0.00495	CcSEcCtD
Mupirocin—Cellulitis—Epirubicin—pancreatic cancer	0.00485	0.00492	CcSEcCtD
Mupirocin—Epistaxis—Fluorouracil—pancreatic cancer	0.00478	0.00485	CcSEcCtD
Mupirocin—Haemoglobin—Irinotecan—pancreatic cancer	0.00477	0.00484	CcSEcCtD
Mupirocin—Rhinitis—Irinotecan—pancreatic cancer	0.00476	0.00483	CcSEcCtD
Mupirocin—Haemorrhage—Irinotecan—pancreatic cancer	0.00475	0.00482	CcSEcCtD
Mupirocin—Haemoglobin—Gemcitabine—pancreatic cancer	0.00465	0.00471	CcSEcCtD
Mupirocin—Rhinitis—Gemcitabine—pancreatic cancer	0.00464	0.0047	CcSEcCtD
Mupirocin—Haemorrhage—Gemcitabine—pancreatic cancer	0.00463	0.00469	CcSEcCtD
Mupirocin—Skin disorder—Erlotinib—pancreatic cancer	0.0046	0.00466	CcSEcCtD
Mupirocin—Pharyngitis—Gemcitabine—pancreatic cancer	0.00459	0.00466	CcSEcCtD
Mupirocin—Angioedema—Sunitinib—pancreatic cancer	0.00459	0.00465	CcSEcCtD
Mupirocin—Haemoglobin—Fluorouracil—pancreatic cancer	0.00457	0.00464	CcSEcCtD
Mupirocin—Rhinitis—Fluorouracil—pancreatic cancer	0.00456	0.00462	CcSEcCtD
Mupirocin—Haemorrhage—Fluorouracil—pancreatic cancer	0.00455	0.00461	CcSEcCtD
Mupirocin—Pharyngitis—Fluorouracil—pancreatic cancer	0.00452	0.00458	CcSEcCtD
Mupirocin—Cellulitis—Doxorubicin—pancreatic cancer	0.00449	0.00455	CcSEcCtD
Mupirocin—Cough—Sunitinib—pancreatic cancer	0.00438	0.00444	CcSEcCtD
Mupirocin—Dermatitis contact—Epirubicin—pancreatic cancer	0.00436	0.00442	CcSEcCtD
Mupirocin—Dry skin—Docetaxel—pancreatic cancer	0.00435	0.00441	CcSEcCtD
Mupirocin—Immune system disorder—Irinotecan—pancreatic cancer	0.00429	0.00435	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00424	0.0043	CcSEcCtD
Mupirocin—Dry mouth—Sunitinib—pancreatic cancer	0.00418	0.00424	CcSEcCtD
Mupirocin—Immune system disorder—Gemcitabine—pancreatic cancer	0.00418	0.00424	CcSEcCtD
Mupirocin—Pain—Tamoxifen—pancreatic cancer	0.00409	0.00415	CcSEcCtD
Mupirocin—IARS—pancreas—pancreatic cancer	0.00408	0.305	CbGeAlD
Mupirocin—Pain—Erlotinib—pancreatic cancer	0.00405	0.0041	CcSEcCtD
Mupirocin—Dermatitis contact—Doxorubicin—pancreatic cancer	0.00403	0.00409	CcSEcCtD
Mupirocin—Erythema—Gemcitabine—pancreatic cancer	0.00403	0.00408	CcSEcCtD
Mupirocin—Mouth ulceration—Epirubicin—pancreatic cancer	0.00399	0.00404	CcSEcCtD
Mupirocin—Skin disorder—Sunitinib—pancreatic cancer	0.00398	0.00403	CcSEcCtD
Mupirocin—Erythema—Fluorouracil—pancreatic cancer	0.00396	0.00401	CcSEcCtD
Mupirocin—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00391	0.00396	CcSEcCtD
Mupirocin—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00387	0.00392	CcSEcCtD
Mupirocin—Urticaria—Tamoxifen—pancreatic cancer	0.0038	0.00385	CcSEcCtD
Mupirocin—Abdominal pain—Tamoxifen—pancreatic cancer	0.00378	0.00383	CcSEcCtD
Mupirocin—Abdominal pain—Erlotinib—pancreatic cancer	0.00374	0.00379	CcSEcCtD
Mupirocin—Mouth ulceration—Doxorubicin—pancreatic cancer	0.00369	0.00374	CcSEcCtD
Mupirocin—Cough—Irinotecan—pancreatic cancer	0.00361	0.00366	CcSEcCtD
Mupirocin—Eczema—Epirubicin—pancreatic cancer	0.00356	0.00361	CcSEcCtD
Mupirocin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00352	0.00357	CcSEcCtD
Mupirocin—Cough—Gemcitabine—pancreatic cancer	0.00352	0.00356	CcSEcCtD
Mupirocin—Pain—Sunitinib—pancreatic cancer	0.0035	0.00355	CcSEcCtD
Mupirocin—IARS—digestive system—pancreatic cancer	0.00348	0.261	CbGeAlD
Mupirocin—Epistaxis—Docetaxel—pancreatic cancer	0.00345	0.0035	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00341	0.00345	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.00339	0.00344	CcSEcCtD
Mupirocin—Pruritus—Tamoxifen—pancreatic cancer	0.00338	0.00343	CcSEcCtD
Mupirocin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00338	0.00342	CcSEcCtD
Mupirocin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00335	0.0034	CcSEcCtD
Mupirocin—Pruritus—Erlotinib—pancreatic cancer	0.00335	0.00339	CcSEcCtD
Mupirocin—Haemoglobin—Docetaxel—pancreatic cancer	0.0033	0.00335	CcSEcCtD
Mupirocin—Eczema—Doxorubicin—pancreatic cancer	0.0033	0.00334	CcSEcCtD
Mupirocin—Rhinitis—Docetaxel—pancreatic cancer	0.00329	0.00334	CcSEcCtD
Mupirocin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00329	0.00333	CcSEcCtD
Mupirocin—Haemorrhage—Docetaxel—pancreatic cancer	0.00328	0.00333	CcSEcCtD
Mupirocin—Diarrhoea—Tamoxifen—pancreatic cancer	0.00327	0.00332	CcSEcCtD
Mupirocin—Pharyngitis—Docetaxel—pancreatic cancer	0.00326	0.0033	CcSEcCtD
Mupirocin—Abdominal pain—Sunitinib—pancreatic cancer	0.00324	0.00328	CcSEcCtD
Mupirocin—Diarrhoea—Erlotinib—pancreatic cancer	0.00324	0.00328	CcSEcCtD
Mupirocin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00323	0.00328	CcSEcCtD
Mupirocin—Skin disorder—Gemcitabine—pancreatic cancer	0.00319	0.00324	CcSEcCtD
Mupirocin—Dizziness—Tamoxifen—pancreatic cancer	0.00316	0.00321	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.00314	0.00318	CcSEcCtD
Mupirocin—Dizziness—Erlotinib—pancreatic cancer	0.00313	0.00317	CcSEcCtD
Mupirocin—Hypersensitivity—Sunitinib—pancreatic cancer	0.00302	0.00306	CcSEcCtD
Mupirocin—Rash—Tamoxifen—pancreatic cancer	0.00302	0.00306	CcSEcCtD
Mupirocin—Dermatitis—Tamoxifen—pancreatic cancer	0.00301	0.00305	CcSEcCtD
Mupirocin—Headache—Tamoxifen—pancreatic cancer	0.003	0.00304	CcSEcCtD
Mupirocin—Rash—Erlotinib—pancreatic cancer	0.00298	0.00302	CcSEcCtD
Mupirocin—Dermatitis—Erlotinib—pancreatic cancer	0.00298	0.00302	CcSEcCtD
Mupirocin—Immune system disorder—Docetaxel—pancreatic cancer	0.00297	0.00301	CcSEcCtD
Mupirocin—Headache—Erlotinib—pancreatic cancer	0.00297	0.00301	CcSEcCtD
Mupirocin—Dry skin—Epirubicin—pancreatic cancer	0.00293	0.00297	CcSEcCtD
Mupirocin—Pruritus—Sunitinib—pancreatic cancer	0.0029	0.00294	CcSEcCtD
Mupirocin—Pain—Irinotecan—pancreatic cancer	0.00289	0.00293	CcSEcCtD
Mupirocin—Erythema—Docetaxel—pancreatic cancer	0.00286	0.0029	CcSEcCtD
Mupirocin—Nausea—Tamoxifen—pancreatic cancer	0.00284	0.00288	CcSEcCtD
Mupirocin—Pain—Gemcitabine—pancreatic cancer	0.00281	0.00285	CcSEcCtD
Mupirocin—Nausea—Erlotinib—pancreatic cancer	0.00281	0.00285	CcSEcCtD
Mupirocin—Diarrhoea—Sunitinib—pancreatic cancer	0.0028	0.00284	CcSEcCtD
Mupirocin—Dysgeusia—Docetaxel—pancreatic cancer	0.0028	0.00284	CcSEcCtD
Mupirocin—Pain—Fluorouracil—pancreatic cancer	0.00276	0.0028	CcSEcCtD
Mupirocin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00276	0.0028	CcSEcCtD
Mupirocin—Dry skin—Doxorubicin—pancreatic cancer	0.00272	0.00275	CcSEcCtD
Mupirocin—Dizziness—Sunitinib—pancreatic cancer	0.00271	0.00275	CcSEcCtD
Mupirocin—Abdominal pain—Irinotecan—pancreatic cancer	0.00267	0.0027	CcSEcCtD
Mupirocin—Rash—Sunitinib—pancreatic cancer	0.00258	0.00262	CcSEcCtD
Mupirocin—Dermatitis—Sunitinib—pancreatic cancer	0.00258	0.00262	CcSEcCtD
Mupirocin—Urticaria—Fluorouracil—pancreatic cancer	0.00257	0.0026	CcSEcCtD
Mupirocin—Headache—Sunitinib—pancreatic cancer	0.00257	0.0026	CcSEcCtD
Mupirocin—Cough—Docetaxel—pancreatic cancer	0.00249	0.00253	CcSEcCtD
Mupirocin—Hypersensitivity—Irinotecan—pancreatic cancer	0.00249	0.00252	CcSEcCtD
Mupirocin—Nausea—Sunitinib—pancreatic cancer	0.00243	0.00247	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00242	0.00245	CcSEcCtD
Mupirocin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00238	0.00241	CcSEcCtD
Mupirocin—Dry mouth—Docetaxel—pancreatic cancer	0.00238	0.00241	CcSEcCtD
Mupirocin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00233	0.00236	CcSEcCtD
Mupirocin—Epistaxis—Epirubicin—pancreatic cancer	0.00233	0.00236	CcSEcCtD
Mupirocin—Pruritus—Gemcitabine—pancreatic cancer	0.00233	0.00236	CcSEcCtD
Mupirocin—Diarrhoea—Irinotecan—pancreatic cancer	0.00231	0.00234	CcSEcCtD
Mupirocin—Pruritus—Fluorouracil—pancreatic cancer	0.00229	0.00232	CcSEcCtD
Mupirocin—Skin disorder—Docetaxel—pancreatic cancer	0.00227	0.0023	CcSEcCtD
Mupirocin—Diarrhoea—Gemcitabine—pancreatic cancer	0.00225	0.00228	CcSEcCtD
Mupirocin—Dizziness—Irinotecan—pancreatic cancer	0.00223	0.00226	CcSEcCtD
Mupirocin—Haemoglobin—Epirubicin—pancreatic cancer	0.00223	0.00226	CcSEcCtD
Mupirocin—Rhinitis—Epirubicin—pancreatic cancer	0.00222	0.00225	CcSEcCtD
Mupirocin—Haemorrhage—Epirubicin—pancreatic cancer	0.00222	0.00225	CcSEcCtD
Mupirocin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00221	0.00224	CcSEcCtD
Mupirocin—Pharyngitis—Epirubicin—pancreatic cancer	0.0022	0.00223	CcSEcCtD
Mupirocin—Epistaxis—Doxorubicin—pancreatic cancer	0.00215	0.00218	CcSEcCtD
Mupirocin—Dizziness—Fluorouracil—pancreatic cancer	0.00214	0.00217	CcSEcCtD
Mupirocin—Rash—Irinotecan—pancreatic cancer	0.00213	0.00216	CcSEcCtD
Mupirocin—Dermatitis—Irinotecan—pancreatic cancer	0.00213	0.00215	CcSEcCtD
Mupirocin—Headache—Irinotecan—pancreatic cancer	0.00211	0.00214	CcSEcCtD
Mupirocin—Rash—Gemcitabine—pancreatic cancer	0.00207	0.0021	CcSEcCtD
Mupirocin—Dermatitis—Gemcitabine—pancreatic cancer	0.00207	0.0021	CcSEcCtD
Mupirocin—Haemoglobin—Doxorubicin—pancreatic cancer	0.00206	0.00209	CcSEcCtD
Mupirocin—Headache—Gemcitabine—pancreatic cancer	0.00206	0.00209	CcSEcCtD
Mupirocin—Rhinitis—Doxorubicin—pancreatic cancer	0.00205	0.00208	CcSEcCtD
Mupirocin—Haemorrhage—Doxorubicin—pancreatic cancer	0.00205	0.00208	CcSEcCtD
Mupirocin—Rash—Fluorouracil—pancreatic cancer	0.00204	0.00207	CcSEcCtD
Mupirocin—Dermatitis—Fluorouracil—pancreatic cancer	0.00204	0.00206	CcSEcCtD
Mupirocin—Pharyngitis—Doxorubicin—pancreatic cancer	0.00203	0.00206	CcSEcCtD
Mupirocin—Headache—Fluorouracil—pancreatic cancer	0.00203	0.00205	CcSEcCtD
Mupirocin—Nausea—Irinotecan—pancreatic cancer	0.002	0.00203	CcSEcCtD
Mupirocin—Immune system disorder—Epirubicin—pancreatic cancer	0.002	0.00203	CcSEcCtD
Mupirocin—Pain—Docetaxel—pancreatic cancer	0.002	0.00202	CcSEcCtD
Mupirocin—Nausea—Gemcitabine—pancreatic cancer	0.00195	0.00198	CcSEcCtD
Mupirocin—Erythema—Epirubicin—pancreatic cancer	0.00193	0.00195	CcSEcCtD
Mupirocin—Nausea—Fluorouracil—pancreatic cancer	0.00192	0.00195	CcSEcCtD
Mupirocin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00191	0.00193	CcSEcCtD
Mupirocin—Dysgeusia—Epirubicin—pancreatic cancer	0.00189	0.00191	CcSEcCtD
Mupirocin—Immune system disorder—Doxorubicin—pancreatic cancer	0.00185	0.00188	CcSEcCtD
Mupirocin—Abdominal pain—Docetaxel—pancreatic cancer	0.00184	0.00187	CcSEcCtD
Mupirocin—Erythema—Doxorubicin—pancreatic cancer	0.00178	0.00181	CcSEcCtD
Mupirocin—Dysgeusia—Doxorubicin—pancreatic cancer	0.00175	0.00177	CcSEcCtD
Mupirocin—Hypersensitivity—Docetaxel—pancreatic cancer	0.00172	0.00174	CcSEcCtD
Mupirocin—Cough—Epirubicin—pancreatic cancer	0.00168	0.00171	CcSEcCtD
Mupirocin—Pruritus—Docetaxel—pancreatic cancer	0.00165	0.00167	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00163	0.00165	CcSEcCtD
Mupirocin—Dry mouth—Epirubicin—pancreatic cancer	0.00161	0.00163	CcSEcCtD
Mupirocin—Diarrhoea—Docetaxel—pancreatic cancer	0.0016	0.00162	CcSEcCtD
Mupirocin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00157	0.0016	CcSEcCtD
Mupirocin—Cough—Doxorubicin—pancreatic cancer	0.00156	0.00158	CcSEcCtD
Mupirocin—Dizziness—Docetaxel—pancreatic cancer	0.00154	0.00156	CcSEcCtD
Mupirocin—Skin disorder—Epirubicin—pancreatic cancer	0.00153	0.00155	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00151	0.00153	CcSEcCtD
Mupirocin—Dry mouth—Doxorubicin—pancreatic cancer	0.00149	0.00151	CcSEcCtD
Mupirocin—Rash—Docetaxel—pancreatic cancer	0.00147	0.00149	CcSEcCtD
Mupirocin—Dermatitis—Docetaxel—pancreatic cancer	0.00147	0.00149	CcSEcCtD
Mupirocin—Headache—Docetaxel—pancreatic cancer	0.00146	0.00148	CcSEcCtD
Mupirocin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00146	0.00148	CcSEcCtD
Mupirocin—Skin disorder—Doxorubicin—pancreatic cancer	0.00141	0.00143	CcSEcCtD
Mupirocin—Nausea—Docetaxel—pancreatic cancer	0.00139	0.0014	CcSEcCtD
Mupirocin—Pain—Epirubicin—pancreatic cancer	0.00135	0.00136	CcSEcCtD
Mupirocin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00129	0.0013	CcSEcCtD
Mupirocin—Urticaria—Epirubicin—pancreatic cancer	0.00125	0.00127	CcSEcCtD
Mupirocin—Pain—Doxorubicin—pancreatic cancer	0.00125	0.00126	CcSEcCtD
Mupirocin—Abdominal pain—Epirubicin—pancreatic cancer	0.00124	0.00126	CcSEcCtD
Mupirocin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00119	0.00121	CcSEcCtD
Mupirocin—Hypersensitivity—Epirubicin—pancreatic cancer	0.00116	0.00118	CcSEcCtD
Mupirocin—Urticaria—Doxorubicin—pancreatic cancer	0.00116	0.00117	CcSEcCtD
Mupirocin—Abdominal pain—Doxorubicin—pancreatic cancer	0.00115	0.00117	CcSEcCtD
Mupirocin—Pruritus—Epirubicin—pancreatic cancer	0.00111	0.00113	CcSEcCtD
Mupirocin—Diarrhoea—Epirubicin—pancreatic cancer	0.00108	0.00109	CcSEcCtD
Mupirocin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00107	0.00109	CcSEcCtD
Mupirocin—Dizziness—Epirubicin—pancreatic cancer	0.00104	0.00105	CcSEcCtD
Mupirocin—Pruritus—Doxorubicin—pancreatic cancer	0.00103	0.00104	CcSEcCtD
Mupirocin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000996	0.00101	CcSEcCtD
Mupirocin—Rash—Epirubicin—pancreatic cancer	0.000992	0.00101	CcSEcCtD
Mupirocin—Dermatitis—Epirubicin—pancreatic cancer	0.000991	0.001	CcSEcCtD
Mupirocin—Headache—Epirubicin—pancreatic cancer	0.000986	0.000999	CcSEcCtD
Mupirocin—Dizziness—Doxorubicin—pancreatic cancer	0.000963	0.000976	CcSEcCtD
Mupirocin—Nausea—Epirubicin—pancreatic cancer	0.000935	0.000947	CcSEcCtD
Mupirocin—Rash—Doxorubicin—pancreatic cancer	0.000918	0.000931	CcSEcCtD
Mupirocin—Dermatitis—Doxorubicin—pancreatic cancer	0.000917	0.00093	CcSEcCtD
Mupirocin—Headache—Doxorubicin—pancreatic cancer	0.000912	0.000925	CcSEcCtD
Mupirocin—Nausea—Doxorubicin—pancreatic cancer	0.000865	0.000877	CcSEcCtD
